XML 152 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Schedule of common stock issued roll forward

 

Year Ended December 31,

2023

2022

2021

Common stock:

Balance, beginning of year

171,656,030

155,516,284

146,677,786

Shares issued for stock options exercised

832,993

2,105,237

3,155,170

Agent growth incentive stock compensation

2,219,881

2,571,569

2,037,942

Agent equity stock compensation

8,897,804

11,462,940

3,645,386

Balance, end of year

183,606,708

171,656,030

155,516,284

Schedule of Restricted stock activity

The following table illustrates the Company’s stock activity for the Agent Growth Incentive Program for stock awards where the performance metric has been achieved for the following periods:

Weighted Average

Grant Date

    

Shares

    

Fair Value

Balance, December 31, 2021

5,174,654

$ 13.92

Granted

3,829,990

15.29

Vested and issued

(2,542,696)

6.28

Forfeited

(762,951)

18.80

Balance, December 31, 2022

5,698,997

$ 17.68

Granted

4,642,035

15.04

Vested and issued

(2,219,881)

11.73

Forfeited

(1,245,862)

17.35

Balance, December 31, 2023

6,875,289

$17.80

Schedule of stock options fair value assumptions

2023

2022

2021

Expected term

5 - 6 years

5 - 6 years

5 - 6 years

Expected volatility

73.64% - 76.78%

72.84% - 76.49%

68.85% - 86.33%

Risk-free interest rate

3.28% - 4.86%

1.49% - 4.10%

0.44% - 1.33%

Dividend yield

0.72% - 1.64%

0.53% - 1.48%

0.00% - 0.00%

Schedule of stock option activity

Weighted

Average

Weighted

Remaining

Average

Contractual Term

    

Options

    

Exercise Price

    

Intrinsic Value

    

(Years)

Balance December 31, 2021

7,038,660

$ 8.70

$ 25.45

6.26

Granted

1,234,847

19.25

-

9.37

Exercised

(2,083,016)

0.68

18.10

 —

Forfeited

(415,969)

13.68

8.74

 —

Balance at December 31, 2022

5,774,522

$ 13.56

$ 2.21

7.63

Granted

2,468,299

14.81

-

8.46

Exercised

(832,993)

5.90

14.97

 —

Forfeited

(1,198,706)

17.77

2.27

 —

Expired

(12,578)

35.54

0.29

 —

Balance at December 31, 2023

6,198,544

$ 14.23

$ 3.62

7.29

Exercisable at December 31, 2023

3,623,819

$ 12.30

$ 5.31

6.11

Vested at December 31, 2023

3,623,819

$ 12.30

$ 5.31

6.11

Weighted

Average

Options

    

Exercise Price

Range of stock option exercise prices at December 31, 2023:

$0.01 - $10.00 (average remaining life - 6.12 years)

2,573,627

$ 8.18

$10.01 - $30.00 (average remaining life - 8.20 years)

3,315,284

$ 16.59

$30.01 - $60.00 (average remaining life - 7.42 years)

309,633

$ 39.29

Schedule of shares repurchased

Year Ended December 31,

2023

2022

2021

Treasury stock:

Balance, beginning of year

18,816,791

6,751,692

2,534,494

Repurchases of common stock

10,110,152

12,408,430

4,217,198

Forfeiture to treasury stock for acquisition

10,728

-

-

Issuance of treasury stock for acquisition

-

(343,331)

-

Balance, end of year

28,937,671

18,816,791

6,751,692

Agent Growth Incentive Program  
Changes in the Company's stock compensation liability

The following table illustrates changes in the Company’s stock compensation liability for the periods presented:

Amount

Stock grant liability balance at December 31, 2021

$ 4,341

Stock grant liability increase year to date

2,056

Stock grants reclassified from liability to equity year to date

(2,512)

Balance, December 31, 2022

$ 3,885

Stock grant liability increase year to date

3,832

Stock grants reclassified from liability to equity year to date

(2,717)

Balance, December 31, 2023

$ 5,000